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Abstract
Responsible innovation in health (RIH) takes the ideas of responsible research and innovation (RRI) and applies 
them to the health sector. This comment takes its point of departure from Lehoux et al which describes a 
structured literature review to determine the system-level challenges that health systems in countries at different 
levels of human development face. This approach offers interesting insights from the perspective of RRI, but 
it also raises the question whether and how RRI can be steered and achieved across healthcare systems. This 
includes the question who, if anybody, is responsible for responsible innovation and which insights can be 
drawn from the systemic nature RIH. 
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Responsible Innovation in Health (RIH) is a concept put forward by Lehoux et al.1 It draws on the discourse surrounding responsible innovation2 or responsible 
research and innovation (RRI).3 The idea behind these 
concepts is to ensure that research and innovation activities 
are acceptable, desirable and sustainable. RIH takes these 
ideas and transfers them to the health sector. In their paper 
Lehoux et al1 present the findings from a structured literature 
review that aimed to identify system-level challenges that 
health systems currently face. The idea motivating this 
research is that an understanding of the key challenges facing 
a health system can guide innovations and innovation policy, 
to ensure that their consequences promote the public good 
and that the overall innovation process is thereby responsible.
This approach is interesting from the point of view of 
responsible innovation in that it attempts to answer a question 
which is often not addressed, namely the question of the 
intended and desirable outcomes that motivate an innovator. 
Focusing on system-level challenges sidesteps the question 
of which ethical or other values need to motivate responsible 
innovation to render it responsible. The approach has the 
advantage of offering the potential of a practical goal to be 
pursued. By focusing on systems-level challenges, the paper 
moves beyond the focus on the individual researcher, research 
lab or institute that much of the literature on responsible 
innovation focuses on and thereby highlights a key aspect of 
responsible innovation that is often under investigated.
The paper is furthermore interesting in that it splits these 
system-level challenges of health systems in accordance with 
the level of development of the countries in question. It is 
plausible that health systems in richer countries have different 
priorities or problems and require different approaches from 
those in poorer countries. Lehoux et al1 demonstrate that this 
intuition is supported by evidence from the literature.
When looking at the system-level challenges presented in 
the paper, it becomes clear, however, that this high-level view 
is not sufficient to really grasp the problems that healthcare 
systems face in practice. The aggregate data presented in 
the paper remains too abstract to provide practical insights. 
For example, the categories of challenges that are most 
pressing in all four groups of countries with different levels 
of development are in all cases health service delivery, human 
resources or leadership and governance. There are differences 
in ranking these between different groups of countries, with 
health service delivery being a more pronounced problem in 
countries with a higher human development index, whereas 
human resources is seen as the number one problem in 
countries with lower scores on the higher human development 
index. However, I would assume that human resources 
challenges will look very different in different health systems, 
but in order to understand what the challenges in fact are, one 
would have to go back to the original publications that were 
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analysed for the review. The approach can therefore be said to 
be interesting in that it proposes new ways of thinking about 
RIH and the emphasis that research and innovation policy 
should pursue, but it does not move far enough to allow 
deducing practical suggestions. 
Having said this, the paper is still an interesting contribution 
to the debate around responsible innovation. One aspect that 
I found particularly stimulating is the fact that the paper 
raises the question of the relationship between innovations 
and the high-level aims which such innovation is meant to 
achieve. The reason why this question is implicitly posed by 
the paper is that the analysis of the system-level challenges 
and individual innovation activities becomes very difficult 
to establish. The system-level challenges are mostly issues 
of the broader context of innovation and directly related to 
the socio-economic constitution of the society that they find 
themselves.
Challenges that are discussed in the paper include 
frugal innovation, ie, low-cost, local- or community-
based innovation that deals with financial pressure on 
health system and contribute to affordability of health care. 
Challenges related to human resources can be translated into 
requirements for innovation to be easy to use and thereby 
require less training. Another key challenge is that of the 
influence of economic incentives on the governance of health 
systems which is closely related to regulatory frameworks 
and market dynamics. Questions of infrastructure capacity 
and distribution systems form another group of important 
challenges across various types of health systems. A final set 
of issues is related to knowledge and knowledge management, 
in particular the use of IT-based solutions and services.
What this list of key challenges demonstrates is that the 
main issues that systems have to contend with are not so 
much based on available technologies, drugs or facilities but 
on the socio-economic make-up of the healthcare system 
itself. Problems here have to do with distribution of resources, 
principles of distribution of access and are fundamentally 
related to the equitable treatment of different groups and 
demographics. Most of these issues are broadly independent 
of research and innovation activity. In fact, I would 
argue that the impact that the majority of health-related 
innovations have on the larger scale healthcare systems is 
largely undetermined. To put it differently, whether a new 
piece of information technology saves money and makes 
healthcare more available or costs more money and reduces 
the availability of healthcare provision is not a function of the 
innovation itself, but of the environment in which it is put to 
use. This argument is informed by a long tradition of research 
that argues for the co-construction of science, technology and 
society. It is difficult to impossible to separate the innovation 
itself from the environment in which it is used. Technologies 
are always designed for specific environments and users, 
whether intentionally or unintentionally.4 At the same time, 
the logical malleabitlity in particular of information and 
communication technologies5 means that their degree of 
interpretive flexibility,6 ie, the difficulty of predicting their 
eventual use and its consequences is even higher than it is for 
other technologies. The problem with the high level review 
undertaken by Lehoux et al1 is that this context specificity 
of the technology is in danger of becoming invisible and the 
technology can be interpreted as context independent. 
This raises interesting questions around the possibility and 
usefulness of RIH and the distribution of responsibilities that 
would render RIH effective. It would mean that the question 
whether a particular innovation is considered as an expression 
of responsibility is largely independent of the process of 
innovation as well as its eventual outputs. The nature of the 
innovation as being responsible would be determined by 
the eventual use that it is put to in a particular healthcare 
system. This, in turn, has the interesting side effect that the 
place of responsibility is no longer located with the individual 
researcher, research group or institution but resides on a 
higher level in the healthcare system. Such a conclusion would 
go counter to the majority of literature in RRI which tends to 
focus on responsibilities of the researcher or the organisation 
that this undertaking the research.
This situation thus begs the question posed in the title 
of this paper: who is actually responsible for responsible 
innovation? If responsible innovation is about ensuring the 
desirability, acceptability and sustainability of research and 
innovation processes and products, then who is in a position 
to influence those and steer them in a desirable direction? 
Much of the literature on responsible innovation focuses on 
the responsibilities of researchers or research institutions. 
One interpretation of the Lehoux et al1 paper could be to 
reject this focus and explore whether and to what degree other 
stakeholders, groups or institutions can be seen as responsible 
for the outcomes of health innovation. 
I will not pretend that I have an easy answer to the question 
of who is responsible for health innovation. However, it would 
seem to reinforce the importance of reconsidering the very 
notion of responsible innovation. I have argued elsewhere 
that a useful reading of the idea of responsible innovation 
is that of a “higher-level or meta-responsibility that aims 
to shape, maintain, develop, coordinate and align existing 
and novel research and innovation-related processes, actors 
and responsibilities with a view to ensuring desirable and 
acceptable research outcomes.”7 This idea is based on the 
recognition that the responsibilities that each human being 
has are complex, overlapping and interwoven. They are better 
understood as overlapping networks than as simple linear 
attributions.8,9 These suggestions are based on the insight 
that technologies are products of the social environment 
of their creation and use that can be found in the various 
streams of literature that inform the discourse of RRI, such 
as philosophy of technology,10 computer and information 
ethics,11 technology assessment12 or science and technology 
studies.13,14
What this means for RIH is that a first requirement for 
responsible innovation is a better understanding of the existing 
networks of responsibility in a particular healthcare system. 
This will require difficult investigations into complex political 
processes, for example with regards to how incentives are 
defined and determined which pathways exist from research 
funding to the introduction of innovative technologies or 
services in a healthcare setting. The outcome of a particular 
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innovation as meeting the system-level challenges and thus 
being counted as responsible, will depend on the interplay 
of a potentially large number of individuals and institutions. 
The eventual success or lack thereof is largely outside of the 
control of any one individual and notably beyond what could 
be expected from an individual researcher or innovator. 
This then brings us back to the question formulated in the 
title: who is responsible for responsible innovation? The answer 
seems to be elusive there is no individual, group or institution 
that carries responsibility for responsible innovation. This 
may lead to several different possible conclusions: One could 
argue that there is nobody who is responsible for responsible 
innovation and that, at best, it is an unpredictable outcome of 
a systemic interplay of numerous agents. 
A different conclusion might be that following the idea of 
responsible innovation requires rethinking the entire research 
and innovation ecosystem with a view to ensuring that 
innovation processes and outcomes meet societal goals. This 
would probably require a messy intervention into the research 
and innovation policy system, which will need the input from 
all stakeholder groups, including patients, researchers, head 
providers, policy-makers and others. What exactly such an 
intervention might look like is difficult to predict and is also 
not clear whether it would be successful. However, if we do not 
go down this route then the conclusion may be that there is 
nobody who is responsible for responsible innovation and it is 
not clear to me whether it then remains meaningful and useful 
to speak of responsible innovation or RIH. The conclusion one 
could therefore draw from Lehoux et al’s paper is that it calls 
for an entire research programme to understand the research 
and innovation life cycle and ecosystem to determine how the 
system-level outcomes described in the paper can be achieved 
and responsible innovation can be realised. Such research has 
already begun (see, for example, Williams and Woodson15) 
but will require significant efforts to come to fruition.
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